| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | $1,215.83 | Strong Buy | $1,347.00 | +10.79% | a day ago | |
Analyst RankingTop 5% #220 out of 5316 analysts Average Return+21.1% Win Rate66%92 out of 140 Risk vs RewardPoor Good Analyst ColorMorgan Stanley's Terence Flynn raised their price target on Eli Lilly & Co (NYSE: LLY) by 0.2% from $1,344 to $1,347 on 2026/07/08. The analyst maintained their Strong Buy rating on the stock. Eli Lilly & Co. is expected report its Q2 2026 earnings on 2026/08/05. Raising their price target in a Biotech sector preview note, Flynn argued that Eli Lilly & Co. could benefit from broader market leadership and lower interest rates, with historical data showing strong performance in falling rate environments because of the company's rate sensitivity. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | 2 days ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||